0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders

Buy Now

Antiangiogenic Cancer Therapy (Hardcover) Loot Price: R8,276
Discovery Miles 82 760
Antiangiogenic Cancer Therapy (Hardcover): Darren W. Davis, Roy S. Herbst, James L Abbruzzese

Antiangiogenic Cancer Therapy (Hardcover)

Darren W. Davis, Roy S. Herbst, James L Abbruzzese

 (sign in to rate)
Loot Price R8,276 Discovery Miles 82 760 | Repayment Terms: R776 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

Top Investigators Explore the Complexities of Angiogenesis Cancer Research The targeting of tumor angiogenesis has evolved into one of the most widely pursued therapeutic strategies. However, as of yet, no antiangiogenic agent used as a monotherapy has demonstrated a survival benefit in a randomized Phase III trial. The combination of bevacizumab, the first FDA approved angiogenesis inhibitor, with cytotoxic regimens has led to survival benefits in cancer patients. This has raised important questions about the complexities inherent in the clinical application of angiogenesis inhibitors. Compiles the results of four decades of progress Integrating fundamental concepts with therapeutic strategies, Anti-Angiogenic Cancer Therapy promotes the idea that an understanding of the molecular and cellular regulation of angiogenesis leads to optimal therapeutic strategies and positive clinical results. It brings together contributions from leading researchers to provide the most authoritative and encyclopedic volume available on this subject. Examines the role of angiogenesis in cancer, including strategies to prolong the nonangiogenic dormant state of human tumors, molecular mechanisms and cellular regulation of angiogenesis in solid tumors and hematologic malignancies, and the regulation of angiogenesis by the tumor microenvironment. Covers specific molecular targets for inhibiting angiogenesis in cancer therapy. Discusses clinical trial design and translational research approaches essential for identifying and developing effective angiogenesis inhibitors. Outlines current understanding of the molecular biology of each cancer type followed by discussions that examine strategies for targeting angiogenesis in specific cancers. This volume celebrates progress made in four decades, and more importantly, it provi

General

Imprint: Crc Press
Country of origin: United States
Release date: July 2007
First published: 2008
Editors: Darren W. Davis • Roy S. Herbst • James L Abbruzzese
Dimensions: 254 x 178 x 58mm (L x W x T)
Format: Hardcover
Pages: 864
ISBN-13: 978-0-8493-2799-5
Categories: Books > Medicine > Clinical & internal medicine > Diseases & disorders > General
LSN: 0-8493-2799-7
Barcode: 9780849327995

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners